JPWO2021002355A1 - - Google Patents

Info

Publication number
JPWO2021002355A1
JPWO2021002355A1 JP2021530034A JP2021530034A JPWO2021002355A1 JP WO2021002355 A1 JPWO2021002355 A1 JP WO2021002355A1 JP 2021530034 A JP2021530034 A JP 2021530034A JP 2021530034 A JP2021530034 A JP 2021530034A JP WO2021002355 A1 JPWO2021002355 A1 JP WO2021002355A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021530034A
Other languages
Japanese (ja)
Other versions
JPWO2021002355A5 (https=
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021002355A1 publication Critical patent/JPWO2021002355A1/ja
Publication of JPWO2021002355A5 publication Critical patent/JPWO2021002355A5/ja
Priority to JP2025026012A priority Critical patent/JP2025084816A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/24—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the mouth, i.e. stomatoscopes, e.g. with tongue depressors; Instruments for opening or keeping open the mouth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00147—Holding or positioning arrangements
    • A61B1/00148—Holding or positioning arrangements using anchoring means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/05—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances characterised by the image sensor, e.g. camera, being in the distal end portion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0077—Devices for viewing the surface of the body, e.g. camera, magnifying lens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0088—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for oral or dental tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Measuring devices for evaluating the respiratory organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
    • A61B5/201—Assessing renal or kidney functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4866—Evaluating metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6814—Head
    • A61B5/682—Mouth, e.g., oral cavity; tongue; Lips; Teeth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/20—Heterogeneous data integration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Theoretical Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Quality & Reliability (AREA)
  • General Physics & Mathematics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
JP2021530034A 2019-07-03 2020-06-30 Pending JPWO2021002355A1 (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025026012A JP2025084816A (ja) 2019-07-03 2025-02-20 インフルエンザウイルス感染症を治療するための医薬組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019124750 2019-07-03
PCT/JP2020/025652 WO2021002355A1 (ja) 2019-07-03 2020-06-30 インフルエンザウイルス感染症を治療するための医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025026012A Division JP2025084816A (ja) 2019-07-03 2025-02-20 インフルエンザウイルス感染症を治療するための医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2021002355A1 true JPWO2021002355A1 (https=) 2021-01-07
JPWO2021002355A5 JPWO2021002355A5 (https=) 2023-07-05

Family

ID=74101322

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021530034A Pending JPWO2021002355A1 (https=) 2019-07-03 2020-06-30
JP2025026012A Pending JP2025084816A (ja) 2019-07-03 2025-02-20 インフルエンザウイルス感染症を治療するための医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025026012A Pending JP2025084816A (ja) 2019-07-03 2025-02-20 インフルエンザウイルス感染症を治療するための医薬組成物

Country Status (9)

Country Link
US (2) US12245754B2 (https=)
EP (2) EP3995149A4 (https=)
JP (2) JPWO2021002355A1 (https=)
KR (1) KR20220034130A (https=)
CN (2) CN114340637A (https=)
BR (1) BR112021026839A2 (https=)
CA (1) CA3145200A1 (https=)
MX (1) MX2021016040A (https=)
WO (1) WO2021002355A1 (https=)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01148233A (ja) * 1987-12-07 1989-06-09 Olympus Optical Co Ltd マウスピース
JPH0856896A (ja) * 1994-08-23 1996-03-05 Olympus Optical Co Ltd 電子内視鏡
US20040138585A1 (en) * 2001-05-15 2004-07-15 Maurice Dematteis Mouthpeice intended for a device used to assess the sensitivity of the pharynx and a device comprising same
JP2009153923A (ja) * 2007-12-27 2009-07-16 Koichi Tsunoda 口腔挿入具および口腔咽頭鏡装置
JP2015530886A (ja) * 2012-06-27 2015-10-29 バウチャー、ライアン 医療診断情報を取得するための装置、方法、およびシステム、ならびに遠隔医療サービスの提供
WO2016185463A1 (en) * 2015-05-19 2016-11-24 Tyto Care Ltd. Systems and methods for throat imaging
JP2018079216A (ja) * 2016-11-18 2018-05-24 国立大学法人鳥取大学 喉頭鏡及び喉頭鏡用ブレード
JP2018527997A (ja) * 2015-05-12 2018-09-27 ジップライン ヘルス、インク． 医療診断情報を取得するための装置、方法、およびシステム、ならびに遠隔医療サービスの提供

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6257238B1 (en) * 2000-05-25 2001-07-10 Nizam M. Meah Bite block for upper gastrointestinal endoscopy with tongue depressor
US7807174B2 (en) 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
WO2005104926A1 (ja) * 2004-04-30 2005-11-10 J. Morita Manufacturing Corporation 生体観察機器、口腔内撮影装置及び医療用診療器具
WO2009023356A2 (en) * 2007-05-25 2009-02-19 Omega-Biopharma (H.K.) Limited Materials and methods for treating influenza infections
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
CN101787008A (zh) * 2009-01-23 2010-07-28 中国科学院上海药物研究所 N-乙酰神经氨酸类化合物、其药物组合物及其制备方法和用途
US10022449B2 (en) * 2009-12-22 2018-07-17 Marinomed Biotechnologie Gmbh Synergistic antiviral composition and use thereof
US9555094B2 (en) 2012-07-23 2017-01-31 The Institute Of Biological Resources Isolated nucleic acid for the production of a vaccine against virus
HK1209646A1 (en) 2012-12-28 2016-04-08 日本国立感染症研究所 Nasal influenza vaccine composition
MX387277B (es) 2013-03-14 2025-03-12 Contrafect Corp Composiciones basadas en anticuerpos neutralizantes suministrados intranasalmente para eficacia terapéutica aumentada.
US10632010B2 (en) * 2014-04-01 2020-04-28 Oventus Medical Limited Breathing assist device
JP6844088B2 (ja) * 2017-01-25 2021-03-17 株式会社メドレー 医療情報提供方法、医療情報提供装置、及びプログラム
US11104689B2 (en) * 2017-09-18 2021-08-31 Sunshine Lake Pharma Co., Ltd. Influenza virus replication inhibitor and use thereof
JP7267608B2 (ja) 2017-12-28 2023-05-02 アイリス株式会社 口内撮影装置、医療装置及びプログラム
CN109504721B (zh) * 2018-12-26 2021-07-09 杭州科巢生物科技有限公司 一种抗流感药物的合成方法

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01148233A (ja) * 1987-12-07 1989-06-09 Olympus Optical Co Ltd マウスピース
JPH0856896A (ja) * 1994-08-23 1996-03-05 Olympus Optical Co Ltd 電子内視鏡
US20040138585A1 (en) * 2001-05-15 2004-07-15 Maurice Dematteis Mouthpeice intended for a device used to assess the sensitivity of the pharynx and a device comprising same
JP2009153923A (ja) * 2007-12-27 2009-07-16 Koichi Tsunoda 口腔挿入具および口腔咽頭鏡装置
JP2015530886A (ja) * 2012-06-27 2015-10-29 バウチャー、ライアン 医療診断情報を取得するための装置、方法、およびシステム、ならびに遠隔医療サービスの提供
JP2018527997A (ja) * 2015-05-12 2018-09-27 ジップライン ヘルス、インク． 医療診断情報を取得するための装置、方法、およびシステム、ならびに遠隔医療サービスの提供
WO2016185463A1 (en) * 2015-05-19 2016-11-24 Tyto Care Ltd. Systems and methods for throat imaging
JP2018079216A (ja) * 2016-11-18 2018-05-24 国立大学法人鳥取大学 喉頭鏡及び喉頭鏡用ブレード

Also Published As

Publication number Publication date
US20250176815A1 (en) 2025-06-05
EP4599758A2 (en) 2025-08-13
EP3995149A4 (en) 2023-07-19
CN114340637A (zh) 2022-04-12
KR20220034130A (ko) 2022-03-17
CN119679357A (zh) 2025-03-25
CA3145200A1 (en) 2021-01-07
US12245754B2 (en) 2025-03-11
EP3995149A1 (en) 2022-05-11
BR112021026839A2 (pt) 2022-02-22
EP4599758A3 (en) 2025-11-05
JP2025084816A (ja) 2025-06-03
US20220361741A1 (en) 2022-11-17
WO2021002355A1 (ja) 2021-01-07
MX2021016040A (es) 2022-03-11

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021017637A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
BR112021017728A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112019016142A2 (https=)
BR112019016138A2 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)

Legal Events

Date Code Title Description
AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20220322

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220411

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230627

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230627

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20240319

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20240405

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240604

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240801

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20241126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250220